Quick Answer: Hair loss whilst on GLP-1 medications is not typically a direct drug effect but may occur as telogen effluvium triggered by rapid weight loss, nutritional deficiencies, or metabolic stress, and is usually temporary and reversible
The FDA-approved product contains only tirzepatide in its specified concentrations (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection)
Long-term: To manage ongoing health issues if you have insulin resistance or a high chance of regaining weight
At BHRC, our physicians guide you through the entire treatment journey
Details are provided for species and sex effects for CYP1A, 2B, 2E, 3A, and 4A
Further, it may impact pathways associated with sleep dysregulation in research models in laboratory trials